Vetoquinol SA
PAR:VETO

Watchlist Manager
Vetoquinol SA Logo
Vetoquinol SA
PAR:VETO
Watchlist
Price: 79.3 EUR 1.28% Market Closed
Market Cap: 938.2m EUR
Have any thoughts about
Vetoquinol SA?
Write Note

Vetoquinol SA
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Vetoquinol SA
Cash from Investing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Vetoquinol SA
PAR:VETO
Cash from Investing Activities
-€14m
CAGR 3-Years
55%
CAGR 5-Years
28%
CAGR 10-Years
12%
Sanofi SA
PAR:SAN
Cash from Investing Activities
-€6.5B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Ipsen SA
PAR:IPN
Cash from Investing Activities
-€285.3m
CAGR 3-Years
-19%
CAGR 5-Years
25%
CAGR 10-Years
-10%
Virbac SA
PAR:VIRP
Cash from Investing Activities
-€456.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Boiron SA
PAR:BOI
Cash from Investing Activities
-€19.6m
CAGR 3-Years
-3%
CAGR 5-Years
14%
CAGR 10-Years
4%
Medincell SA
PAR:MEDCL
Cash from Investing Activities
-€613k
CAGR 3-Years
17%
CAGR 5-Years
6%
CAGR 10-Years
N/A
No Stocks Found

Vetoquinol SA
Glance View

Market Cap
938.4m EUR
Industry
Pharmaceuticals

Vétoquinol SA operates as a global animal health company. The company is headquartered in Lure, Bourgogne-Franche-Comte. The company went IPO on 2006-11-16. The Company’s product portfolio is divided between livestock, such as cattle and pigs, and companion animals, including dogs and cats. Vetoquinol SA’s offering includes anti-infectives, such as Marbocyl; anti- pain inflammatories, which comprise Tolfedine, intended for dogs and cats, and Tolfine for livestock, and cardiovascular and nephrology treatment, such as Prilium, an oral daily administration formula for dogs, among others. The firm markets over 700 products, in such countries as France, Austria, Canada, Italy, Poland, Spain and the Netherlands, among others. The company trades its products throughout Europe, North America, Africa, the Middle East and Pacific Asia. In April 2014, it acquired Bioniche's animal health business.

VETO Intrinsic Value
86.78 EUR
Undervaluation 9%
Intrinsic Value
Price

See Also

What is Vetoquinol SA's Cash from Investing Activities?
Cash from Investing Activities
-14m EUR

Based on the financial report for Jun 30, 2024, Vetoquinol SA's Cash from Investing Activities amounts to -14m EUR.

What is Vetoquinol SA's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
12%

Over the last year, the Cash from Investing Activities growth was 41%. The average annual Cash from Investing Activities growth rates for Vetoquinol SA have been 55% over the past three years , 28% over the past five years , and 12% over the past ten years .

Back to Top